Sign in
- You are currently accessing unquote.com via your Enterprise account.
  
  If you already have an account please use the link below to sign in.
  
  If you have any problems with your access or would like to request an individual access account please contact our customer service team.
  
  Phone: +44 (0)203 741 1137
  
  Email: Georgina.Lawson@acuris.com
  - Sign in
Follow us
- Twitter
- LinkedIn
Free Trial
Subscribe

Ferd increases stake in Pronova Bio

Tweet
Facebook
LinkedIn
Google plus
Send to

Ferd Private Equity has acquired the remaining shares in Norwegian pharmaceutical company Pronova Biocare. Ferd originally acquired an 80.1% stake in the company in December 2003 for NOK 165m and at the same time secured a loan of NOK 225, which has now been repaid. Pronova Biocare is a world leader in the development, production and sale of marine Omega-3 fatty acids. The company's business is sub-divided into three business areas: pharmaceuticals, consumer brands and industrial brands.

Tweet
Facebook
LinkedIn
Google plus
Send to

Fund closes in US dollars

Funds

Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

05 September 2023

Clinical trials and biotechnology

Buyouts

Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

04 September 2023

Public sector software

Exits

Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

04 September 2023

EMEA Public to Private M&A

Investments

Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

04 September 2023

Back to Top